![Ori Kalid](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ori Kalid
Hoofd Techniek/Wetenschap/O&O bij
PROTALIX BIOTHERAPEUTICS, INC.
Profiel
Ori Kalid was the founder of Pi Therapeutics Ltd., founded in 2015, and held the title of Chief Executive Officer.
Dr. Kalid is currently Vice President-Research & Development at Protalix Biotherapeutics, Inc. since 2024.
Formerly, Dr. Kalid was Chief Executive Officer at Pi Therapeutics Ltd. Dr. Kalid completed undergraduate, graduate, and doctorate degrees at Tel-Aviv University.
Actieve functies van Ori Kalid
| Bedrijven | Functie | Begin |
|---|---|---|
| PROTALIX BIOTHERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-06-2024 |
Eerdere bekende functies van Ori Kalid
| Bedrijven | Functie | Einde |
|---|---|---|
Pi Therapeutics Ltd.
 Pi Therapeutics Ltd. BiotechnologyHealth Technology Develops a proprietary cancer drug | Algemeen Directeur | - |
Pi Therapeutics Ltd.
Pi Therapeutics Ltd. BiotechnologyHealth Technology Develops a proprietary cancer drug | Algemeen Directeur | - |
Opleiding van Ori Kalid
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
3
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protalix Biotherapeutics, Inc.
 Protalix Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets recombinant therapeutic proteins | Health Technology |
Pi Therapeutics Ltd.
Pi Therapeutics Ltd. BiotechnologyHealth Technology Develops a proprietary cancer drug | Health Technology |
